- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
186 |
LISA L. CUNNINGHAM AND JUSTIN TAN |
Like aminoglycosides, cisplatin results in the formation of reactive oxygen species in hair cells, including superoxide. Some thiol antioxidants, including sodium thiosulfate, D-methionine, and lipoic acid, can inhibit cisplatin-induced ototoxicity. However, some of these thiols, including sodium thiosulfate, diminish cisplatin’s tumoricidal activity by the formation of inactive platinum–thiol conjugates.
3.4. Therapeutic strategies to prevent hair cell death
Several cotherapies have been shown to inhibit ototoxic hair cell death in animal model systems. As mentioned previously, a variety of antioxidants can inhibit both aminoglycosideand cisplatin-induced hair cell apoptosis. Similarly, ototoxicity is inhibited by either inhibition of caspase activity or upregulation of antiapoptotic Bcl-2 family members. Interest is emerging in intrinsic protective mechanisms in the inner ear that, if activated, may be able to inhibit hair cell death. One such intrinsic protective mechanism is the activation of heat shock proteins (HSPs). HSP induction is one of the most ubiquitous and highly conserved stress responses in biology. Stress-induced HSP expression promotes cellular survival in a large number of systems, and HSPs can directly inhibit apoptotic signaling. One well-characterized HSP inducer is heat stress, which induces most HSPs and protects cells against a number of stresses. For example, short-term total-body hyperthermia has been shown to protect the retina against light-induced damage and to prevent ischemia-induced death in both cardiomyocytes and hippocampal neurons. Induction of HSPs via either total-body hyperthermia or local hyperthermia inhibits noise-induced hearing loss. Induction of HSPs via heat shock inhibits both cisplatinand aminoglycoside-induced hair cell death in vitro. Hsp70 is both necessary and sufficient to account for this protective effect of heat shock against aminoglycoside-induced hair cell death. Geranylgeranyl acetone, a chemical HSP inducer, inhibits aminoglycoside-induced hair cell death in vitro. Constitutive over-expression of Hsp70 in transgenic mice inhibits aminoglycoside-induced cochlear hair cell death and hearing loss. It is likely that clinical strategies aimed at inhibiting ototoxic hearing loss will involve both inhibition of apoptotic signaling and upregulation of intrinsic protective mechanisms, possibly including HSP induction.
3.5. Challenges to studies of hair cell death
Both aminoglycosides and cisplatin result |
in death |
of sensory hair cells in the inner ear. This |
death is |
inhibited in animal studies by several cotherapies, including antioxidants and caspase inhibition. However, there is currently no commonly used cotherapy for the prevention of either cisplatinor aminoglycosideinduced hair cell toxicity. Studies of apoptosis in the inner ear are complicated by a lack of suitable model systems in which to examine apoptotic signaling. Although several cell lines have been developed from inner ear tissue, no cell line has yet been identified that develops morphological features of hair cells (i.e., stereocilia) and none that is sensitive to both aminoglycosideand cisplatin-induced death. Furthermore, adult mammalian cochlear hair cells do not survive in culture for more than a few hours. Therefore, research into sensory hair cell apoptosis is usually carried out in whole organ cultures, either of the organ of Corti from neonatal rodents or in the macular organs (utricle and/or saccule) from mature rodents. Both of these systems have limitations. First, both yield a mixture of cell types that includes hair cells, supporting cells, stromal cells, and neuronal processes. This nonhomogeneity of the culture makes it difficult to be certain that changes observed by quantitative methods such as real-time reverse-transcriptase polymerase chain reaction and Western blotting occur in the hair cells themselves. Second, results obtained in cultures from neonatal animals may not reflect the degenerative changes that occur in mature hair cells, and differences also may exist between cochlear and vestibular hair cells in their responses to stress. Third, both systems yield very small numbers of hair cells: the mouse organ of Corti and the adult mouse utricle each contain only approximately 3,000 hair cells. This is an extremely small amount of tissue, and this limitation restricts the feasibility of many biochemical and molecular biology techniques that require large numbers of cells. Despite these limitations, significant progress has been made in recent years toward understanding the mechanisms underlying sensory hair cell death and survival.
4. SPIRAL GANGLION NEURON DEATH
When hair cells are destroyed by noise trauma or ototoxic drugs such as aminoglycoside antibiotics and cisplatin, the SGNs show signs of apoptosis within days and continue to degenerate over a lengthy period of time (Figure 17–3). In certain cases, genetic mutations that cause atrophy of the organ of Corti also lead to a corresponding loss of SGNs. Emerging evidence supports the concept that cells lying close to inner and outer hair cells complement the function of the sensory hair cells in promoting SGN survival.
CELL DEATH IN THE INNER EAR |
187 |
4.1. Neurotrophic support from sensory hair cells and supporting cells
Neurotrophins are a major family of molecules that are required for SGN development and survival. The neurotrophins – nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT3), and neurotrophin 4/5 – constitute a family of secreted molecules that provide target-derived guidance cues for neurons and are essential for neuronal survival and function. During development, inner and outer hair cells as well as supporting cells of the organ of Corti express BDNF, NT3, and another type of neurotrophic factor called glial cell–derived neurotrophic factor (GDNF) to varying degrees and in a spatio-temporal pattern. The importance of BDNF and NT3 in inner ear development and SGN survival is demonstrated by knockout mouse models in which deletion of these neurotrophic genes in mice results in both loss of SGNs and retraction or retardation of their peripheral processes to the organ of Corti. Thus BDNF and NT3 can function as target-derived factors to regulate the survival of SGNs and guide their innervation to hair cells in the organ of Corti during development. Recently, it has been suggested that neurotrophin expression in sensory hair cells and supporting cells is increased by another trophic signaling mechanism involving neuregulins produced by SGNs and their receptors, erbB2, present in hair cells. This reciprocal signaling between SGNs and hair cells is thought to increase neurotrophin expression in either supporting cells or hair cells. Consistent with this reasoning, it has been demonstrated that transgenic mice with disrupted erbB signaling demonstrate dramatic loss of SGNs and reduced NT3 expression.
Because neurotrophins need to bind to their cognate receptors to mediate survival, it is reasonable to speculate that mice deficient in these receptors would show corresponding SGN loss. Among these receptors, the tropomyosin-related kinase (Trk) receptor tyrosine kinase B binds selectively to BDNF, whereas TrkC preferentially interacts with NT3. These receptors are expressed in SGNs, and mice deficient in TrkB or TrkC show significant SGN loss and innervation defects at the organ of Corti. Furthermore, TrkB and TrkC double knockout mice display an even more severe SGN loss than either of the single knockout mouse models, underscoring the requirement of both neurotrophins for SGN survival. The importance of these neurotrophins in the inner ear does not appear to be restricted to this developmental window, because sensory hair cells and supporting cells of the adult organ of Corti continue to express BDNF and NT3. In addition, TrkB and TrkC expression
Deafened
Organ of Corti
Scala Vestibuli |
|
|
Scala Media |
|
|
Organ of Corti |
Spiral Limbus |
|
Hair Cells |
||
|
SGNs
Osseous Spiral
Basilar Lamina
Membrane
|
Rosenthal’s |
Modiolus |
|
Scala Tympani |
Canal |
||
|
Figure 17-3. Schematic of the normal and degenerating cochlea. In a cross-section of the mammalian cochlea, inner (labeled with a white dot) and outer (highlighted with asterisks) hair cells in the organ of Corti are innervated by peripheral processes of spiral ganglion neurons (SGNs). Deafness induced by ototoxic drugs or noise results in death of these hair cells in the organ of Corti, leading to secondary degeneration and loss of SGNs (see inset). Adapted with permission from Hurley et al., 2007.
persist in adult SGNs, suggesting an ongoing physiologic role for neurotrophin signaling in adulthood (Figure 17-3).
4.2. Afferent activity from hair cells
In addition to trophic support, SGNs require afferent activity from sensory hair cells for survival. In the organ of Corti, inner hair cells stimulate SGNs by secreting glutamate, which activates two classes of receptors: the N-methyl-D-aspartate and α-amino-3-hy- droxy-5-methylisoxazole-4-propionate receptors. These ligand-gated receptors are ion channels that open on activation, causing an influx of cations into the SGN. This gradually depolarizes the neuron, activating another class of voltage-gated ion channels – the L- type Ca2+ channels. Blockade of L-type Ca2+ channels with inhibitors (nifedipine and verapamil) abolishes the trophic effect of depolarization in SGN cultures, demonstrating that Ca2+ entry is necessary for SGN survival. Furthermore, both glutamate receptors and L-type Ca2+ channels are present in SGNs, suggesting that these ion channels mediate afferent activity initiated by hair cells.
A regulated influx of Ca2+ in neurons is essential to trigger intracellular survival signaling cascades linked to
188 |
LISA L. CUNNINGHAM AND JUSTIN TAN |
SGN survival. Considering the diversity and cross-talk among signaling cascades, one approach to understanding SGN physiology has been to identify the downstream targets that promote survival and then examine the corresponding upstream signaling cascades. Degenerating SGNs show a decline in phosphorylation of the nuclear transcription factor, cyclic adenosine monophosphate response element binding protein (CREB). CREB is a downstream target that is indirectly activated by Ca2+ influx. CREB regulates the expression of many genes necessary for neuronal function and survival. Phosphorylation of CREB can be induced by at least two pathways: the Ras-MAPK pathway and the Ca2+/calmodulindependent kinases, both of which are activated by Ca2+ influx. MAPK and Ca2+/calmodulin-dependent kinases phosphorylate CREB at specific amino acid residues, enabling CREB to bind to distinct nucleotide sequences and promote transcription of selected genes such as BDNF. In primary cultures of postnatal SGNs, inhibitors of either MAPK or Ca2+/calmodulin-dependent kinases reduce SGN survival, suggesting that these pathways are necessary for SGN survival. Because BDNF mRNA transcripts in SGNs are expressed in a manner that is dependent on neuronal activity, it remains likely that BDNF produced by SGNs can promote survival via an autocrine signaling loop involving their TrkB receptors. Another mechanism by which activityinduced depolarization can promote SGN survival is via phosphorylation (inactivation) of proapoptotic Bad by Ca2+ /calmodulin-dependent kinase II.
4.3. Molecular manifestations of spiral ganglion neuron death
The death of SGNs is not remarkably different from that of most other neurons, but we will highlight certain features that are manifested in degenerating SGNs. When aminoglycoside antibiotics are administered to rats to induce hair cell death, a dramatic reduction in TrkB expression in SGNs and their peripheral processes is observed. Concomitantly, increased expression of the p75 neurotrophic receptor (p75NTR) occurs in both SGNs and Schwann cells. Although classified as a neurotrophic receptor like TrkB and TrkC, p75NTR has diverse roles in the nervous system depending on the pathological status of the cells. In healthy cells, the p75NTR receptor can increase the affinity of binding between NGF and its cognate TrkA receptor, or BDNF and TrkB. However, under conditions of trauma and inflammation, p75NTR can trigger apoptosis.
The mechanisms underlying the proapoptotic activity of p75NTR are largely unknown. However, this
signaling may be related to whether the ligand is in a mature or immature form. In their mature forms, neurotrophins BDNF and NT3 support SGN survival. Like many hormones and enzymes, neurotrophins are produced initially as pro-neurotrophin forms consisting of a pro-domain linked to the mature neurotrophin. Proteolytic cleavage releases the mature neurotrophins, enabling them to mediate most of their biological functions, including survival. However, proneurotrophins can bind to p75NTR at subnanomolar concentrations to induce cell death, illustrating the dependence of signaling by neurotrophins on their state (whether proor mature neurotrophin). In rat cochleae exposed to aminoglycoside antibiotics, the accumulation of uncleaved pro-BDNF and the augmented expression of p75NTR in the cochleae suggest that this mechanism may contribute to SGN degeneration. Although it remains to be determined whether this mechanism contributes to SGN death in humans, new lines of evidence support this hypothesis. For example, pro-neurotrophin forms of NGF accumulate in brains of humans with Alzheimer’s disease. Furthermore, pro-NGF isolated from these diseased brains rapidly triggers death in cultured neurons. It is unclear how p75NTR signals cell death, but an increase in JNK activity has been associated with p75NTRdependent apoptosis. In addition, degenerating SGNs show increased phosphorylation of c-Jun, indicating activation of the JNK signaling pathway. Thus, similar to what is known about death of sensory hair cells, activation of the JNK signaling pathway may contribute to SGN apoptosis.
Hair cells do not always perish immediately after ototoxic drug exposure; they sometimes undergo a progressive atrophy with time. In particular, aminoglycoside antibiotics, which have a half-life in serum of approximately 3 to 5 hours, are not efficiently cleared from the inner ear, resulting in an extended half-life in inner ear tissues and fluids that may exceed 30 days. This protracted retention in the cochlea leads to hair cell death, followed by gradual death of SGNs. Apoptotic features can be observed within somas of degenerating SGNs weeks and months after the initial traumatic insult, in part because of the gradual nature of hair cell death. Some of the apoptotic features in degenerating SGNs include increased terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, cytochrome c release, activation of caspase-9, and increases in the caspase-cleaved fragment of poly (ADP-ribose) polymerase. These features suggest the involvement of members of the mitochondrial cell death pathway in regulating apoptosis in SGNs, and over-expression of Bcl-2 in